Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1234 of 6351
-
Can a child's background shape their ICU journey? a new study asks
Knowledge-focused Not yet recruitingThis mixed methods study aims to understand how factors such as ethnicity, deprivation, language, and access to healthcare affect outcomes for children admitted to paediatric intensive care (PICU). The main questions it aims to answer are: * Why are some children more likely to…
Sponsor: Imperial College London • Aim: Knowledge-focused
Last updated Aug 20, 2026 00:00 UTC
-
Ear stimulation may rewire fear responses in PTSD
Disease control Not yet recruitingThe goal of this study is to determine how non-invasive brain stimulation (delivered through the ear called vagus nerve stimulation) affects fear learning processes in people who have experienced psychological trauma. To answer these questions, we measure bodily responses (heart …
Early phase 1 • Sponsor: Wayne State University • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Could low blood protein make a common antibiotic riskier after surgery?
Knowledge-focused Not yet recruitingThe goal of this observational study is to learn whether hypoalbuminemia in post surgical patients receiving cefoperazone/sulbactam therapy poses them to the risk of developing coagulopathy. It will also study that what are the other risk factors for the development of cefoperazo…
Sponsor: Sheikh Zayed Federal Postgraduate Medical Institute • Aim: Knowledge-focused
Last updated Aug 23, 2026 00:00 UTC
-
Breathing exercises may retrain swallowing in ICU survivors — a trial puts it to the test
Disease control Not yet recruitingThis research study is investigating the efficacy and implementation of expiratory muscle strength training (EMST), standard of care dysphagia treatment, and intensive dysphagia treatment in critically ill adults in the acute care setting. Currently, no targeted, effective, and f…
Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Sep 10, 2026 02:00 UTC
-
Turmeric compound tested as vaginal treatment for cervical precancer
Disease control Not yet recruitingThe purpose of this study is to see if curcumin can suppress HPV infection in women with low-grade squamous intraepithelial lesions (LSIL) disease or treated high-grade squamous intraepithelial lesions (HSIL) disease. This study plans to explore the effect of curcumin as a potent…
Phase 2 • Sponsor: Lisa Flowers • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Gaming your way to steadier feet: new study tests Dual-Task training for fall prevention
Prevention Not yet recruiting1. Develop an evidence-based dual-task intervention programme incorporating gamification for fall risk reduction in older adults. 2. Examine the effects of the gamified dual-task intervention on fall risk in older adults. 3. Elucidate the underlying mechanisms of the optimal gami…
Sponsor: Jinyao Wang • Aim: Prevention
Last updated Jul 01, 2026 00:00 UTC
-
Double stimulation may restore arm movement in spinal cord injury
Symptom relief Not yet recruitingThis clinical trial investigates whether combining cortical and spinal neuromodulation can improve upper limb motor recovery in adults with chronic incomplete cervical spinal cord injury (SCI). Restoring upper limb function is the top rehabilitation priority for individuals with …
Sponsor: National University Hospital, Singapore • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
Simple swallow check may predict ventilator weaning failure
Knowledge-focused Not yet recruitingExtubation failure, defined as the need for reintubation after planned removal of the endotracheal tube, occurs in up to 20% of critically ill patients and is associated with prolonged mechanical ventilation, longer intensive care unit (ICU) stay, and increased mortality. Current…
Sponsor: Universidade Federal de Pernambuco • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Experimental antibody takes aim at Hard-to-Treat lymphoma
Disease control Recruiting nowThis phase Ib trial tests the safety, side effects, and best dose of teclistamab in treating patients with plasmablastic lymphoma that has come back after a period of improvement (recurrent) or that has not responded to previous treatment (refractory). Teclistamab is a bispecific…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Could a blood test unlock the biology of depression?
Knowledge-focused Not yet recruitingThis is a case control study including simple random cases of 90 persons, 45 of them have depressive disorders and the other 45 are healthy individuals,age group between 18-60 years old, cases will be recruited from outpatient psychiatric clinic in sohag university hospital, all …
Sponsor: Sohag University • Aim: Knowledge-focused
Last updated Aug 22, 2026 00:00 UTC
-
Can a new pill tame inflammatory bowel disease?
Disease control Not yet recruitingThis is a double-blind, randomized, placebo-controlled study, consisting of a single ascending dose (SAD) part with integrated food effect (FE) arm, and a multiple ascending dose (MAD) part to assess the safety, tolerability, and PK of ascending single and multiple oral doses of …
Phase 1 • Sponsor: Lmito Therapeutics Inc. • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New MS drug trial uses Super-Powered MRI to see inside the brain
Disease control Not yet recruitingThe study is an investigator-run, study following participants for 2 years with twice-daily remibrutinib. MRI is the main endpoint. Safety, tolerability, and efficacy are secondary endpoints. Approximately 20 participants with relapsing or progressive forms of MS will be recruite…
Phase 2 • Sponsor: Moein Amin • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Could a lower dose of blood cancer drugs be just as effective?
Disease control Not yet recruitingBLOOD-dose is a multicentre, adaptive, randomized, multidomain platform trial designed to optimize treatment dosing strategies in adult patients with haematological diseases. The BLOOD-dose core protocol outlines the overall clinical trial design that applies to all included int…
Phase 4 • Sponsor: Anne Louise Tølbøll Sørensen • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Texts and referrals aim to catch lung cancer early in ER smokers
Prevention Not yet recruitingThis randomized clinical trial evaluates the effectiveness of text messaging and facilitated referral strategies to increase lung cancer screening uptake among emergency department patients who meet lung cancer screening eligibility criteria.
Sponsor: University of Rochester • Aim: Prevention
Last updated Jun 27, 2026 12:28 UTC
-
New AR game app aims to spark motivation in schizophrenia patients
Symptom relief Not yet recruitingSchizophrenia Spectrum disorders (SSD) are among the most devastating psychiatric disorders. Prominent negative symptoms such as low motivation, anhedonia, asociality, and emotional flattening are experienced by up to 60% of individuals with SSD and are often considered to be the…
Sponsor: North Shore Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Promising drug combo targets aggressive brain cancers in youth
Disease control Not yet recruitingThe goal of this study is to further evaluate feasibility and tolerability of Opdualag for patients with replication repair deficient HGG, including DIPG.
Phase 2 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated Sep 10, 2026 02:00 UTC
-
New hope for brain tumor patients when standard drug fails
Disease control Not yet recruitingThis study will include up to 40 participants with Grade 2 or Grade 3 IDH1-mutant glioma who have undergone surgery and received vorasidenib as their only treatment, experienced radiographic disease progression on vorasidenib (confirmed by Blinded Independent Central Review \[BIC…
Phase 2 • Sponsor: Nuvation Bio Inc. • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Can a custom running plan outperform standard therapy for IT band pain?
Disease control Not yet recruitingPatients with diagnosed iliotibial band (ITB) syndrome indicated for non-operative management will be randomized to individualized exercise program or standard physical therapy over the course of 3 months to determine any possible difference in clinical outcomes.
Sponsor: NYU Langone Health • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
A smartphone app may lighten the load for hispanic dementia caregivers
Symptom relief Not yet recruitingThe goal of this clinical trial is to evaluate usability, feasibility and preliminary efficacy of a mobile telehealth supported behavioral intervention for caregivers of persons with dementia who identify as Hispanic. The main question it aims to answer is: "is a mobile telehealt…
Sponsor: Indiana University • Aim: Symptom relief
Last updated Aug 30, 2026 00:00 UTC
-
New pill could help asthma sufferers breathe easier
Disease control Not yet recruitingThis study explores a potential new treatment for adults with moderate-to-severe asthma using a drug called linvemastat, which targets an enzyme linked to lung inflammation. Despite using standard asthma medications, many patients still struggle with symptoms, so researchers are …
Phase 2 • Sponsor: Foresee Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC